Sarah Greenwood

Sarah Greenwood

Auto-generated profile, based on publicly available information

Sarah Greenwood

University of Saskatchewan, Saskatoon, Saskatchewan, Canada

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2020 in Veterinary Pathology
Verified
Journal Article
Closed access
SGSarah Greenwood
Sarah Greenwood
BCBetty Chow-Lockerbie
Betty Chow-Lockerbie
TETasha Epp
Tasha Epp
CKCameron Knight
Cameron Knight
GWGarrett Wachoski-Dark
Garrett Wachoski-Dark
BWBruce Wobeser
Bruce Wobeser
Equus caballus papillomavirus type-2 (EcPV-2) has been proposed as a causal factor in equine genital squamous cell carcinoma (SCC). This study had 2 objectives: first, calculate the frequency of papillomavirus (PV) and EcPV-2 infection in papillomas, carcinomas in situ (CIS), and SCCs in Western Canadian horses; and second, determine if EcPV-2 status of equine SCCs is associated with overall survival (OS). EcPV-2 status of 115 archived tissue samples, spanning 6 years, was determined using broad spectrum (MY09/11) and EcPV-2-specific polymerase chain reaction (PCR) assays, EcPV-2-E6/E7 chromogenic RNA in situ hybridization (R-ISH), and amplicon sequencing. A retrospective survey gathered data on history, outcome, breeding, treatment, and rationales of referring veterinarians when managing PV-associated diseases. Histologic grade and completeness of surgical margins of SCCs were also considered. EcPV-2 DNA was identified in 10/58 (17%) SCC, 8/27 (30%) papillomas, 0/5 CIS, and 0/11 lesions identified as “other.” Overall, 18/101 (18%) of these lesions were positive for EcPV-2. EcPV-2 was identified in 10/35 (29%) SCCs arising from genital tissues but in 0/22 SCCs from other locations. There was no association between breeding history and EcPV-2 status of genital SCCs. EcPV-2 status of genital SCCs was not associated with OS ( P = .76). The strongest negative predictors of OS were a lack of treatment ( P < .01) and recurrence post-treatment ( P < .01). Weaker predictors of OS included older age at time of diagnosis ( P = .02). Completeness of margins at surgical excision, concurrent disease, treatment type, anatomic location of the SCC (anogenital vs other), and histologic grade of the SCC did not influence OS ( P > .1).

19 August 2020 in Veterinary Pathology
Verified
Journal Article
Open access
PDF file
SGSarah Greenwood
Sarah Greenwood
BCBetty Chow-Lockerbie
Betty Chow-Lockerbie
ARAnna Sophie Ramsauer
Anna Sophie Ramsauer
GWGarrett Wachoski-Dark
Garrett Wachoski-Dark
CKCameron Knight
Cameron Knight
BWBruce Wobeser
Bruce Wobeser
Equus caballus papillomavirus type 2 (EcPV-2) has been recognized as a potential cause of a subset of genital squamous cell carcinomas (SCCs) in horses. In the current study, we measured EcPV-2 seropositivity in 50 healthy horses from Western Canada, and these were compared to a herd of horses with known EcPV-2 exposure. Second, the presence of EcPV-2 DNA was measured using EcPV-2-specific PCR (polymerase chain reaction), performed on a variety of tissues collected at necropsy from 70 horses that lacked any history, gross, or histologic evidence of neoplasia or papillomavirus-associated disease. EcPV-2-specific RNA in situ hybridization (R-ISH) was performed on PCR-positive samples to identify the specific tissues infected. The prevalence of asymptomatic infection with EcPV-2 in Western Canadian horses was 20/70 (29%). Exposure to EcPV-2 as measured by seropositivity was 18/50 (36%). EcPV-2 positivity by anatomic location, as measured by R-ISH, was as follows: penis 10/29 (35%), vulva 5/34 (15%), eyelid 8/68 (12%), oral mucosa 7/65 (11%), skin from muzzle 7/68 (10%), and retropharyngeal lymph node 2/64 (3%). The youngest horses with EcPV-2 infection, based on PCR, were fetuses, suggesting for the first time that vertical transmission of EcPV-2 occurs in horses. The current study observed an increased prevalence of EcPV-2 as compared to previous studies. We suggest that this difference is due to our use of biopsies in place of superficial swabs. We propose that EcPV-2 infection in asymptomatic horses is more common than previously reported and that the virus’ role in equine genital SCCs may be more complex than originally thought.

1 October 2022 in Journal of the American Veterinary Medical Association
Verified
Journal Article
Closed access
PDF file
RNRina Nabeta
Rina Nabeta
SGSarah Greenwood
Sarah Greenwood
ECErica Corda
Erica Corda
"Pathology in Practice" published on 12 May 2022 by American Veterinary Medical Association.